News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
176,959 Results
Type
Article (4151)
Company Profile (23)
Press Release (172785)
Section
Business (74271)
Career Advice (76)
Deals (12417)
Drug Delivery (8)
Drug Development (22833)
Employer Resources (9)
FDA (3958)
Job Trends (4371)
News (111327)
Policy (7573)
Tag
Academia (361)
Allergies (23)
Alliances (8750)
Alzheimer's disease (296)
Approvals (3955)
Bankruptcy (97)
Best Places to Work (3939)
Breast cancer (36)
Cancer (306)
Cardiovascular disease (21)
Career advice (61)
Cell therapy (53)
Clinical research (19164)
Collaboration (78)
Compensation (23)
COVID-19 (471)
Data (407)
Diabetes (36)
Diagnostics (1741)
Earnings (55482)
Events (23525)
Executive appointments (54)
FDA (4093)
Funding (65)
Gene therapy (47)
GLP-1 (121)
Government (668)
Healthcare (5046)
Infectious disease (492)
Inflammatory bowel disease (32)
IPO (7551)
Job creations (605)
Job search strategy (58)
Layoffs (77)
Legal (1466)
Lung cancer (55)
Manufacturing (25)
Medical device (4029)
Medtech (4030)
Mergers & acquisitions (4897)
Metabolic disorders (80)
Multiple sclerosis (22)
Neuroscience (365)
NextGen Class of 2024 (1232)
Non-profit (665)
Northern California (459)
Obesity (34)
Patents (29)
Peanut (21)
People (8687)
Phase I (5161)
Phase II (8114)
Phase III (7435)
Pipeline (231)
Postmarket research (697)
Preclinical (1654)
Press Release (21)
Radiopharmaceuticals (61)
Rare diseases (43)
Real estate (811)
Regulatory (5720)
Research institute (297)
Southern California (404)
Startups (386)
United States (4236)
Vaccines (99)
Weight loss (22)
Date
Today (124)
Last 7 days (488)
Last 30 days (1283)
Last 365 days (12420)
2024 (11128)
2023 (14248)
2022 (15023)
2021 (15442)
2020 (14629)
2019 (11549)
2018 (8555)
2017 (9851)
2016 (7839)
2015 (9547)
2014 (7173)
2013 (5389)
2012 (5767)
2011 (6151)
2010 (5754)
Location
Africa (93)
Arizona (33)
Asia (10168)
Australia (1034)
California (988)
Canada (382)
China (45)
Colorado (50)
Connecticut (43)
Delaware (31)
Europe (22697)
Florida (136)
Georgia (61)
Illinois (73)
Indiana (109)
Kansas (20)
Maine (32)
Maryland (164)
Massachusetts (731)
Michigan (47)
Minnesota (75)
New Jersey (391)
New York (328)
North Carolina (225)
Northern California (459)
Ohio (28)
Pennsylvania (273)
South America (194)
Southern California (404)
Texas (182)
Utah (32)
Virginia (22)
Washington State (140)
176,959 Results for "31".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Galderma’s IL-31 Injection Wins FDA Approval for Skin Disorder Prurigo Nodularis
The Swiss company’s monoclonal antibody Nemluvio is also undergoing regulatory review for atopic dermatitis, which is a potentially larger market for the first-in-class IL-31 blocker.
August 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Epitopea Closes USD $31 million Pre-Series A Financing
October 25, 2024
·
5 min read
Press Releases
Kymera Therapeutics to Report Third Quarter 2024 Financial Results on October 31
October 24, 2024
·
1 min read
Business
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
October 24, 2024
·
3 min read
Business
IGC Reports Financial Results for Fiscal Year Ended March 31, 2024
IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC), a clinical-stage pharmaceutical company, has announced its financial results for the fiscal year ended March 31, 2024 (“Fiscal 2024”).
June 24, 2024
·
9 min read
Business
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024
October 15, 2024
·
2 min read
Press Releases
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
October 28, 2024
·
3 min read
Biotech Beach
Taro Provides Results for Year Ended March 31, 2024
Taro Pharmaceutical Industries Ltd. provided unaudited financial results for the quarter and year ended March 31, 2024.
May 20, 2024
·
9 min read
Press Releases
Evaxion to announce business update and third quarter 2024 financial results on October 31
October 28, 2024
·
3 min read
Business
RaySearch Laboratories: Interim report January 1 - March 31, 2024
RaySearch Laboratories: Interim report January 1 - March 31, 2024.
May 17, 2024
·
2 min read
1 of 17,696
Next
